Cancers · 2022 · 28 citations · 19 references
MedicineOncologyRadiation OncologyClinical Radiation OncologyRadiation DosimetryTreatment PlanningCancer Treatment PlanningDose SchedulingRadiation TherapyRadiation Treatment PlanningRadiobiological ConsiderationsStereotactic RadiotherapyLocal Control AssessmentLung Cancer StagingLung Squamous Cell CarcinomaOptimal Dose SelectionPrognostic Factors AnalysisRadiotherapy Dose PlanningStereotactic Body Radiotherapy DosimetryTreatment Planning Dosimetry
Stereotactic body radiotherapy (SBRT) is a treatment option for early-stage lung cancer. The purpose of this study was to investigate the optimal dose distribution and prognostic factors for local control (LC) after SBRT for lung cancer. A total of 104 lung tumors from 100 patients who underwent SBRT using various treatment regimens were analyzed. Dose distributions were corrected to the biologically effective dose (BED). Clinical and dosimetric factors were tested for association with LC after SBRT. The median follow-up time was 23.8 months (range, 3.4–109.8 months) after SBRT. The 1- and 3-year LC rates were 95.7% and 87.7%, respectively. In univariate and multivariate analyses, pathologically confirmed squamous cell carcinoma (SQ), T2 tumor stage, and a Dmax < 125 Gy (BED10) were associated with worse LC. The LC rate was significantly lower in SQ than in non-SQ among tumors that received a Dmax < 125 Gy (BED10) (p = 0.016). However, there were no significant differences in LC rate between SQ and non-SQ among tumors receiving a Dmax ≥ 125 Gy (BED10) (p = 0.198). To conclude, SQ, T2 stage, and a Dmax < 125 Gy (BED10) were associated with poorer LC. LC may be improved by a higher Dmax of the planning target volume.
19
The National Comprehensive Cancer Network
William T. McGivney · Cancer · 1998 · 16.9K citations
Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinoma
Hiroshi Onishi, Tsutomu Araki, Hiroki Shirato et al. · Cancer · 2004 · 906 citations · Full text
Louis Potters, Brian D. Kavanagh, James M. Galvin et al. · International Journal of Radiation Oncology*Biology*Physics · 2010 · 666 citations